Amcure is a biopharmaceutical company developing first-in-class cancer therapeutics. The company develops peptide-based compounds for the treatment of highly metastatic forms of cancer. amcure’s most advanced development candidate, AMC303, has entered clinical development and has demonstrated in in vivo proof-of-concept studies a high efficacy against different types of epithelial cancers. 
Company growth
Type
Private
HQ
Eggenstein-Leopoldshafen, DE
Founded
2011
Size (employees)
6 (est)
amcure was founded in 2011 and is headquartered in Eggenstein-Leopoldshafen, DE

Key People at amcure

Matthias Klaften

Matthias Klaften

CEO
Alexandra Matzke

Alexandra Matzke

CSO

amcure Office Locations

amcure has office in Eggenstein-Leopoldshafen
Eggenstein-Leopoldshafen, DE

amcure Metrics

amcure Summary

Founding Date

2011

Total Funding

$13.1 M

Latest funding size

$6.37 M

Time since last funding

2 months

Investors

We estimate that amcure's latest funding round in December 2016 was $6.37 M. In total, amcure has raised $13.1 M

amcure Company Life

You may also be interested in